ANDREW RICE to tat Gene Products, Human Immunodeficiency Virus
This is a "connection" page, showing publications ANDREW RICE has written about tat Gene Products, Human Immunodeficiency Virus.
Connection Strength
1.951
-
The HIV-1 Tat Protein: Mechanism of Action and Target for HIV-1 Cure Strategies. Curr Pharm Des. 2017; 23(28):4098-4102.
Score: 0.562
-
P-TEFb as a target to reactivate latent HIV: two Brds are now in hand. Cell Cycle. 2013 Feb 01; 12(3):392-3.
Score: 0.427
-
Identification of novel CDK9 and Cyclin T1-associated protein complexes (CCAPs) whose siRNA depletion enhances HIV-1 Tat function. Retrovirology. 2012 Oct 30; 9:90.
Score: 0.421
-
Unexpected Mutations in HIV-1 That Confer Resistance to the Tat Inhibitor Didehydro-Cortistatin A. mBio. 2019 07 09; 10(4).
Score: 0.167
-
Subversion of Cell Cycle Regulatory Mechanisms by HIV. Cell Host Microbe. 2015 Jun 10; 17(6):736-40.
Score: 0.126
-
Cyclin T1-dependent genes in activated CD4 T and macrophage cell lines appear enriched in HIV-1 co-factors. PLoS One. 2008 Sep 05; 3(9):e3146.
Score: 0.079
-
HIV-1 infection and regulation of Tat function in macrophages. Int J Biochem Cell Biol. 2004 Sep; 36(9):1767-75.
Score: 0.060
-
Regulation of TAK/P-TEFb in CD4+ T lymphocytes and macrophages. Curr HIV Res. 2003 Oct; 1(4):395-404.
Score: 0.056
-
Transient induction of cyclin T1 during human macrophage differentiation regulates human immunodeficiency virus type 1 Tat transactivation function. J Virol. 2002 Nov; 76(21):10579-87.
Score: 0.053